Cancer gene therapy using plasmid DNA: Pharmacokinetics and safety evaluation of an IL-2 plasmid DNA expression vector in rodents and nonhuman primates

BioPharm

Volumn 12, Issue 4, 1999, Pages 18-24

  Parker, S E ^a   Vahlsing, H L ^a   Lew, D ^a   Martin, T ^a   Hall, B ^a   Kornbrust, D ^a   Norman, J ^a  

^a VICAL INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 2; LEUVECTIN; PLASMID DNA; UNCLASSIFIED DRUG;

BLOOD CHEMISTRY; CANCER IMMUNOTHERAPY; DNA DRUG COMPLEX; DOSE TIME EFFECT RELATION; DRUG HALF LIFE; DRUG SAFETY; DRUG SYNTHESIS; GENE EXPRESSION REGULATION; GENE THERAPY; INTRATUMORAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PLASMID; PROTEIN EXPRESSION; REVIEW; RHESUS MONKEY; TISSUE DISTRIBUTION;

EID: 0033047419     PISSN: 10408304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)